Aurora Cannabis Stock News

Aurora Cannabis completes reverse share split to maintain NASDAQ listing requirements. Positive developments include five quarters of positive adjusted EBITDA, debt repayment, and guidance for positiv

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at

People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks.

Investors are working on various strategies to see returns from their marijuana stock investments. As most who are active in the sector can see the upward momentum is not consistent. Much of the way c

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration

Aurora Cannabis has plenty of company-specific problems made worse by the challenging state of its industry. Peloton's pandemic tailwind is over, and the business is now struggling under the weight of

In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for invest

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.14 per share a year ago.

Aurora Cannabis Inc. (ACB) Q3 2024 Earnings Call Transcript

Aurora Cannabis (NASDAQ: ACB ) stock is climbing higher on Thursday after completing its acquisition of MedReleaf Australia. Aurora Cannabis used a wholly-owned subsidiary to acquire the 90% stake in

Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) shares moved higher in early trade on Thursday after the Alberta-based medical cannabis firm reaffirmed that it is on track to achieve positive free cash flow

Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million). Details of Aurora-MedReleaf transaction The li

Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-relate

The last decade saw a trend for destigmatization of the use of psychoactive substances accompanied by a wave of legislation either legalizing or decriminalizing mostly marijuana-based products – bot

Aurora Cannabis's latest earnings report showed some improvement. Still, the company's prospects in the industry are hard to predict.